HealthTechmemeabout 1 hour ago
Dassault in talks to buy ArisGlobal for $2B
1 min read
Dassault Systèmes is in talks to acquire ArisGlobal, a drug trial software maker, from Nordic Capital for about $2 billion. The potential purchase would extend the French conglomerate's push into life sciences.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
